GNI GROUP LTD.
Contact Us
About Us
About Us TOP
Message
Business Model
Main Products
Management Policy
Company Overview
Board of Directors
Main Group Structure
Office
Corporate governance
R&D
R&D TOP
Pipeline
Discovery Research
Research publications
Investor Relations
Investor Relations TOP
IR News
Information
IR Materials
IR Calendar
IR Email Subscription
Electronic Public Notices
Sustainability/ESG
Sustainability/ESG TOP
Sustainability Initiatives
ESG Data
Contact Us
Site Map
Privacy Policy
Terms of Use
ソーシャルメディアポリシー
NEWS
Patent Allowance for Pirfenidone／F647 and its Derivative’s Use in Radiation-Caused Lung Injury
トップページ
News
Patent Allowance for Pirfenidone／F647 and its Derivative’s Use in Radiation-Caused Lung Injury
2012.06.12
